Kimberley Doucette is an Oncology physician affiliated with Georgetown University. OpenAlex indexes 51 publications with 395 citations (h-index 8); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3800 Reservoir Rd NW
Washington, DC 200072113
Telephone
202-444-3736Provider last certified this registry record 26 Jan 2022.
Clinical trials
- Daratumumab for Polyneuropathy Associated With MGUS
Sponsor: Georgetown University
- Phase IB/II of CPX-351 for Relapse Prevention in AML
Sponsor: Georgetown University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
25 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20258 payments
- Legend Biotech USA Inc.Program year20252 payments
- Takeda Pharmaceuticals U.S.A., Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
40%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor40%Acyclovir100%Part D<11 patientsAnti-infectives
33.3%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor33.3%Valacyclovir100%Part D<11 patientsCancer & immunology
26.7%Thalidomide Analog26.7%Revlimid100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Augusto Pichard, MD
Georgetown University
Virginia Steen
Georgetown University
Joseph Verbalis
Georgetown University
Craig Kessler
Georgetown University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”